National Medical Products Administration: Precisely support the development of innovative medical devices, focus on key areas to achieve breakthroughs

National Medical Products Administration News: On February 4-5, the 2026 National Medical Device Supervision and Management Work Conference was held in Shenyang City. The meeting outlined six key tasks for 2026 medical device regulation work: First, jointly promote the formulation of the “14th Five-Year” plan, systematically plan work deployment, and scientifically set development goals; Second, build a more comprehensive regulatory system and standards framework, actively advance legislation, and continuously improve institutional design; Third, precisely support the development of innovative medical devices, continuously release policy dividends, and focus on key breakthroughs; Fourth, improve the quality and efficiency of medical device registration and filing, deepen standardized governance, and maintain consistent standards; Fifth, comprehensively manage safety risks, enhance the quality and effectiveness of risk consultation operations, strengthen supervision with a problem-oriented approach, and severely punish illegal activities; Sixth, fully enhance regulatory professional capabilities, deepen international exchanges and cooperation, and actively build a new pattern of joint governance. (People’s Financial News)